Molecular Imaging of Breast Cancer: Present and future directions
Medical imaging technologies have undergone explosive growth over the past few decades and now play a central role in clinical oncology. But the truly transformative power of imaging in the clinical management of cancer patients lies ahead. Today, imaging is at a crossroads, with molecularly targete...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2014-12-01
|
| Series: | Frontiers in Chemistry |
| Subjects: | |
| Online Access: | http://journal.frontiersin.org/Journal/10.3389/fchem.2014.00112/full |
| _version_ | 1818007853805338624 |
|---|---|
| author | David eAlcantara Manuel ePernia Leal Irene eGarcia Maria Luisa eGarcia-Martin |
| author_facet | David eAlcantara Manuel ePernia Leal Irene eGarcia Maria Luisa eGarcia-Martin |
| author_sort | David eAlcantara |
| collection | DOAJ |
| description | Medical imaging technologies have undergone explosive growth over the past few decades and now play a central role in clinical oncology. But the truly transformative power of imaging in the clinical management of cancer patients lies ahead. Today, imaging is at a crossroads, with molecularly targeted imaging agents expected to broadly expand the capabilities of conventional anatomical imaging methods. Molecular imaging will allow clinicians to not only see where a tumour is located in the body, but also to visualize the expression and activity of specific molecules (e.g. proteases and protein kinases) and biological processes (e.g. apoptosis, angiogenesis, and metastasis) that influence tumour behavior and/or response to therapy. Breast cancer, the most common cancer among women and a research area where our group is actively involved, is a very heterogeneous disease with diverse patterns of development and response to treatment. Hence, molecular imaging is expected to have a major impact on this type of cancer, leading to important improvements in diagnosis, individualized treatment, and drug development, as well as our understanding of how breast cancer arises. |
| first_indexed | 2024-04-14T05:21:14Z |
| format | Article |
| id | doaj.art-1cfec3c98e994cb69a73001f0ab0e2a5 |
| institution | Directory Open Access Journal |
| issn | 2296-2646 |
| language | English |
| last_indexed | 2024-04-14T05:21:14Z |
| publishDate | 2014-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Chemistry |
| spelling | doaj.art-1cfec3c98e994cb69a73001f0ab0e2a52022-12-22T02:10:10ZengFrontiers Media S.A.Frontiers in Chemistry2296-26462014-12-01210.3389/fchem.2014.00112122546Molecular Imaging of Breast Cancer: Present and future directionsDavid eAlcantara0Manuel ePernia Leal1Irene eGarcia2Maria Luisa eGarcia-Martin3Fundacion Publica Andaluza Progreso y SaludFundacion Publica Andaluza Progreso y SaludFundacion Publica Andaluza Progreso y SaludFundacion Publica Andaluza Progreso y SaludMedical imaging technologies have undergone explosive growth over the past few decades and now play a central role in clinical oncology. But the truly transformative power of imaging in the clinical management of cancer patients lies ahead. Today, imaging is at a crossroads, with molecularly targeted imaging agents expected to broadly expand the capabilities of conventional anatomical imaging methods. Molecular imaging will allow clinicians to not only see where a tumour is located in the body, but also to visualize the expression and activity of specific molecules (e.g. proteases and protein kinases) and biological processes (e.g. apoptosis, angiogenesis, and metastasis) that influence tumour behavior and/or response to therapy. Breast cancer, the most common cancer among women and a research area where our group is actively involved, is a very heterogeneous disease with diverse patterns of development and response to treatment. Hence, molecular imaging is expected to have a major impact on this type of cancer, leading to important improvements in diagnosis, individualized treatment, and drug development, as well as our understanding of how breast cancer arises.http://journal.frontiersin.org/Journal/10.3389/fchem.2014.00112/fullbreast cancerbreast cancer diagnosisBreast magnetic resonance imagingMolecular Imaging of breastbreast cancer contrast agentBreast Imaging Techniques |
| spellingShingle | David eAlcantara Manuel ePernia Leal Irene eGarcia Maria Luisa eGarcia-Martin Molecular Imaging of Breast Cancer: Present and future directions Frontiers in Chemistry breast cancer breast cancer diagnosis Breast magnetic resonance imaging Molecular Imaging of breast breast cancer contrast agent Breast Imaging Techniques |
| title | Molecular Imaging of Breast Cancer: Present and future directions |
| title_full | Molecular Imaging of Breast Cancer: Present and future directions |
| title_fullStr | Molecular Imaging of Breast Cancer: Present and future directions |
| title_full_unstemmed | Molecular Imaging of Breast Cancer: Present and future directions |
| title_short | Molecular Imaging of Breast Cancer: Present and future directions |
| title_sort | molecular imaging of breast cancer present and future directions |
| topic | breast cancer breast cancer diagnosis Breast magnetic resonance imaging Molecular Imaging of breast breast cancer contrast agent Breast Imaging Techniques |
| url | http://journal.frontiersin.org/Journal/10.3389/fchem.2014.00112/full |
| work_keys_str_mv | AT davidealcantara molecularimagingofbreastcancerpresentandfuturedirections AT manuelepernialeal molecularimagingofbreastcancerpresentandfuturedirections AT ireneegarcia molecularimagingofbreastcancerpresentandfuturedirections AT marialuisaegarciamartin molecularimagingofbreastcancerpresentandfuturedirections |